{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:30:37Z","timestamp":1792197037295,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX000273-07"],"award-info":[{"award-number":["I01 BX000273-07"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["UO1 NS074926"],"award-info":[{"award-number":["UO1 NS074926"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005909","name":"UC Mexus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Conacyt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012196","name":"James and Debbie Cho Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yebeh.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T13:33:37Z","timestamp":1571405617000},"page":"106367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"PB","title":["Early polytherapy for benzodiazepine-refractory status epilepticus"],"prefix":"10.1016","volume":"101","author":[{"given":"Jerome","family":"Niquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"de Araujo Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Suchomelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireri","family":"Franco-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude G.","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.06.011_bb0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2019.06.011_bb0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-4886(87)90293-7","article-title":"Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats","volume":"97","author":"Morrisett","year":"1987","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0020","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0030","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0035","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.yebeh.2019.06.011_bb0040","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.06.011_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.yebeh.2019.06.011_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/0748233706th268oa","article-title":"Development of a rat pilocarpine model of seizure\/status epilepticus that mimics chemical warfare nerve agent exposure","volume":"22","author":"Tetz","year":"2006","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.06.011_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"7604","key":"10.1016\/j.yebeh.2019.06.011_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0085","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.06.011_bb0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004691-199110000-00004","article-title":"Principles for transformation of scalp EEG from potential field into source distribution","volume":"8","author":"Hjorth","year":"1991","journal-title":"J Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.06.011_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(96)00203-X","article-title":"The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus","volume":"725","author":"Fujikawa","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nbd.2009.10.019","article-title":"Vulnerability of postnatal hippocampal neurons to seizures varies regionally with their maturational stage","volume":"37","author":"Lopez-Meraz","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.yebeh.2019.06.011_bb0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"de Araujo Furtado","year":"2010","journal-title":"Epilepsia."},{"issue":"1","key":"10.1016\/j.yebeh.2019.06.011_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods"},{"issue":"3","key":"10.1016\/j.yebeh.2019.06.011_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0120","series-title":"Drug synergism and dose-effect data analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.yebeh.2019.06.011_bb0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0140","first-page":"853","article-title":"The use of body surface area as a criterion of drug dosage in cancer chemotherapy","volume":"18","author":"Pinkel","year":"1958","journal-title":"Cancer Res"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0145","series-title":"Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","year":"2005"},{"issue":"3","key":"10.1016\/j.yebeh.2019.06.011_bb0150","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.yebeh.2019.06.011_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clon.2006.10.010","article-title":"Chemotherapy dosing part I: scientific basis for current practice and use of body surface area","volume":"19","author":"Kaestner","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"S5","key":"10.1016\/j.yebeh.2019.06.011_bb0160","first-page":"24","article-title":"Management of status epilepticus","volume":"31","author":"Gezalian","year":"2014","journal-title":"Fed Pract"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:53:57Z","timestamp":1719978837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019304329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"alternative-id":["S1525505019304329"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.011","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early polytherapy for benzodiazepine-refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106367"}}